NCT06587568

Brief Summary

The goal of this pilot randomized controlled trial is to evaluate the trial feasibility and acceptability of mobile chat messaging for reducing alcohol use among patients with chronic liver diseases. Specific objectives include:

  1. 1.To assess whether the eligibility criteria were too restrictive by estimating the eligibility rate
  2. 2.To assess how many eligible CLD patients accepted the invitation to participate in the trial
  3. 3.To assess the participant retention rate through 6 months after treatment initiation
  4. 4.To assess the intervention acceptability in terms of participants' engagement with and rating of the chat messaging intervention.
  5. 5.To assess the safety of the intervention
  6. 6.To estimate the intervention effect on alcohol use outcomes and liver functions
  7. 7.To synthesise data to inform the sample size calculation in the future definitive trial
  8. 8.To explore the participants' perception and experiences in the chat-based intervention

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
106

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 5, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
13 days until next milestone

Study Start

First participant enrolled

October 2, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

May 1, 2025

Status Verified

April 1, 2025

Enrollment Period

1.2 years

First QC Date

September 5, 2024

Last Update Submit

April 28, 2025

Conditions

Keywords

drinkingcirrhosishepatitisSBIRTWhatsAppChinesemHealthABI

Outcome Measures

Primary Outcomes (3)

  • Recruitment rate

    Number of participants divided by the number of eligible subjects

    Through recruitment completion, about 8 months

  • Retention rate

    Number of participants completed the follow-up divided by the number of participants

    6 months after randomisation

  • Weekly alcohol consumption

    Assessed by questions 1 and 2 of AUDIT-C

    6 months after randomisation

Secondary Outcomes (12)

  • Eligibility rate

    Through recruitment completion, about 8 months

  • Weekly alcohol consumption

    3 months after randomisation

  • Frequency of heavy episodic drinking

    3 months after randomisation

  • Frequency of heavy episodic drinking

    6 months after randomisation

  • AUDIT score and level

    3 months after randomisation

  • +7 more secondary outcomes

Study Arms (2)

Mobile chat messaging

EXPERIMENTAL

Mobile chat messaging + Screening-based alcohol intervention

Behavioral: Mobile chat messagingBehavioral: Screening, brief intervention and referral to treatment

Brief intervention

ACTIVE COMPARATOR

Screening-based alcohol intervention only

Behavioral: Screening, brief intervention and referral to treatment

Interventions

A trained counsellor will interact with a participant individually and provide personalised alcohol reduction information and advice via a mobile instant messaging app in real time for 3 months from randomisation.

Mobile chat messaging

Brief counselling (5 to 10 mins) to reduce drinking and a self-help booklet

Also known as: SBIRT
Brief interventionMobile chat messaging

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years
  • Diagnosed with chronic liver disease
  • Alcohol Use Disorders Identification Test score ≥8
  • Own a smartphone with a mobile instant messaging app installed
  • Able to read and communicate in Chinese

You may not qualify if:

  • Having a psychiatric or psychological disease or on psychotropic drugs
  • Participating in other alcohol reduction or abstinence programmes
  • Require emergency or in-patient treatment after consultation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Queen Mary Hospital

Hong Kong, Hong Kong

Location

MeSH Terms

Conditions

FibrosisHepatitis

Interventions

Mass ScreeningCrisis Intervention

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsLiver DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosisHealth SurveysSurveys and QuestionnairesData CollectionEpidemiologic MethodsInvestigative TechniquesDiagnostic ServicesPreventive Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthPublic Health PracticePsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Tzu Tsun Luk, PhD, RN

    The University of Hong Kong

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant Professor

Study Record Dates

First Submitted

September 5, 2024

First Posted

September 19, 2024

Study Start

October 2, 2024

Primary Completion

November 30, 2025

Study Completion

December 31, 2025

Last Updated

May 1, 2025

Record last verified: 2025-04

Locations